Hiroshi Kawai, Ph.D.
Board Director CEO
Kyoto Univ., Ph.D.(Biochemistry),
Mitsubishi Tanabe, Mitsubishi Tanabe Holdings America
Led Business Development for 15 years
2019/10 Director of Socium.
2020/6 Board Director of Socium
Katsuhisa Horimoto, Ph.D.
Board Director CTO, Funder
Tokyo Univ. of Science, Ph.D.(Biophysics),The Univ. of Tokyo, AIST
>130 peer-reviewed papers on computational systems biology, 8 parents of algorithms
2017/9 CTO, Co-founder of Socium
2019/4 Invited Researcher of AIST, Visiting Professor of Saitama Medical Univ.
Junya Yamazaki, Ph.D.
Kyoto Univ., Ph.D. (Molecular Biology)
Goldman Sachs, Jefferies, Takeda
Equity research, R&D finance, Portfolio management, BD support
2019/6 Principal of UTEC
2019/10 Board Director of Socium
Atsushi Shimada Patent atony, MBA
IE Business School., MBA,
2018/4 Venture Partner of UTEC,
2018/4 VP of Socium
Masashi Kitazawa, Ph.D.
Astellas Pharma, AIST,
Led drug target discovery projects in academic and corporate research
2018/4 Manager of Socium.
2019/10 Director of Socium
Director Corporate Administration
Yokohama City Univ.,BA.(Accounting),KPMG AZSA LLC, SCS consulting HK.
Led Audit, financial advisory, listed in HK Main Board as IPO project manager
2019/6 Director of Socium